Association of thyroid status prior to transition to end-stage renal disease with early dialysis mortality

被引:11
|
作者
You, Amy S. [1 ]
Sim, John J. [2 ]
Kovesdy, Csaba P. [3 ,4 ]
Streja, Elani [1 ,5 ]
Nguyen, Danh V. [6 ]
Brent, Gregory A. [7 ,8 ]
Kalantar-Zadeh, Kamyar [1 ,5 ]
Rhee, Connie M. [1 ]
机构
[1] Univ Calif Irvine, Harold Simmons Ctr Kidney Dis Res & Epidemiol, Sch Med, Orange, CA 92668 USA
[2] Kaiser Permanente Southern Calif, Dept Nephrol, Los Angeles, CA USA
[3] Univ Tennessee, Ctr Hlth Sci, Div Nephrol, Memphis, TN 38163 USA
[4] Memphis Vet Affairs Med Ctr, Nephrol Sect, Memphis, TN USA
[5] Tibor Rubin Vet Affairs Med Ctr, Long Beach, CA USA
[6] Univ Calif Irvine, Div Gen Internal Med, Orange, CA 92668 USA
[7] Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA
[8] Vet Affairs Greater Los Angeles Healthcare Syst, Dept Med, Los Angeles, CA USA
基金
美国国家卫生研究院;
关键词
incident ESRD; mortality; pre-ESRD prelude; thyroid; transition; QUALITY-OF-LIFE; SUBCLINICAL HYPOTHYROIDISM; NONTHYROIDAL ILLNESS; FUNCTIONAL DISEASE; KIDNEY-DISEASE; HORMONE LEVELS; DOUBLE-BLIND; RISK-FACTOR; HEMODIALYSIS; TRIIODOTHYRONINE;
D O I
10.1093/ndt/gfy289
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Advanced chronic kidney disease (CKD) patients, including those receiving dialysis, have a high prevalence of thyroid dysfunction. Although hypothyroidism is associated with higher death risk in end-stage renal disease (ESRD) patients, no studies have examined whether thyroid status in the pre-ESRD period impacts mortality after dialysis initiation. Methods. Among US veterans with CKD identified from the national Veterans Affairs database that transitioned to dialysis over the period from October 2007 to September 2011, we examined the association of pre-ESRD serum thyrotropin (TSH) levels averaged over the 1-year pre-dialysis ('prelude') period with all-cause mortality in the first year following dialysis initiation. Results. Among 15 335 patients in the 1-year prelude cohort, TSH levels >5.0 mIU/L were associated with higher mortality in expanded case-mix Cox models (reference: TSH 0.5-5.0 mIU/L): adjusted hazard ratio (aHR) [95% confidence interval (CI) 1.20 (1.07-1.33). Similar findings were observed for TSH >5.0 mIU/L and mortality in the 2- and 5-year cohorts: aHRs (95% CI) 1.11 (1.02-1.21) and 1.15 (1.07-1.24), respectively. Analyses of finer gradations of TSH in the 1-year prelude cohort demonstrated that incrementally higher levels >5.0 mIU/L were associated with increasingly higher mortality in expanded case-mix models (reference: TSH 0.5-3.0 mIU/L): aHRs (95% CI) 1.18 (1.04-1.33) and 1.28 (1.03-1.59) for TSH levels >5.0-10.0 mIU/L and >10.0 mIU/L, respectively. In the 2- and 5-year cohorts, mortality associations persisted most strongly for those with TSH >10.0 mIU/L, particularly after laboratory covariate adjustment. Conclusions. Among new ESRD patients, there is a dose-dependent relationship between higher pre-ESRD TSH levels >5.0 mIU/L and post-ESRD mortality. Further studies are needed to determine the impact of TSH reduction with thyroid hormone supplementation in this population.
引用
收藏
页码:2095 / 2104
页数:11
相关论文
共 50 条
  • [31] End-stage renal disease and peritoneal dialysis in Bulgaria
    Vazelov, ES
    Krivoshiev, SG
    Antonov, SA
    Lazarov, G
    [J]. PERITONEAL DIALYSIS INTERNATIONAL, 2004, 24 (06): : 512 - 517
  • [32] Chronic inflammation in end-stage renal disease and dialysis
    Cobo, Gabriela
    Lindholm, Bengt
    Stenvinkel, Peter
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 : 35 - 40
  • [33] TREATMENT OF END-STAGE RENAL-DISEASE BY DIALYSIS
    BLAGG, CR
    [J]. TRANSPLANTATION PROCEEDINGS, 1985, 17 (01) : 1497 - 1499
  • [34] Peritoneal dialysis in children with end-stage renal disease
    Franz Schaefer
    Bradley A. Warady
    [J]. Nature Reviews Nephrology, 2011, 7 : 659 - 668
  • [35] Peritoneal dialysis in children with end-stage renal disease
    Schaefer, Franz
    Warady, Bradley A.
    [J]. NATURE REVIEWS NEPHROLOGY, 2011, 7 (11) : 659 - 668
  • [36] Optimizing the Transition to End-Stage Renal Disease
    Tamura, Manjula Kurella
    [J]. SEMINARS IN NEPHROLOGY, 2017, 37 (02) : 113 - 113
  • [37] Effects of dialysis modality on mortality in patients with end-stage renal disease: A cohort study
    Du, Liang
    Sun, Heqi
    Lu, Jun
    Chen, Gang
    Ye, Jianming
    Zhuang, Ye
    Gao, Lanying
    Xiong, Yan
    [J]. SEMINARS IN DIALYSIS, 2023, 36 (02) : 155 - 161
  • [38] Thyroid Function Tests in End-Stage Renal Disease
    Kulkarni, Dhananjay P.
    Holley, Jean L.
    [J]. SEMINARS IN DIALYSIS, 2014, 27 (06) : 552 - 555
  • [39] RENAL-CARCINOMA AND DIALYSIS IN END-STAGE RENAL-DISEASE
    OLSSON, PJ
    FIERER, JA
    KELLY, CE
    WRIGHT, RW
    BLAISE, D
    ANDERSON, KB
    PETERSON, JC
    ALEXANDER, RW
    [J]. SOUTHERN MEDICAL JOURNAL, 1985, 78 (05) : 507 - 512
  • [40] Early Start of Dialysis Has No Survival Benefit in End-Stage Renal Disease Patients
    Chang, Jae Hyun
    Rim, Min Young
    Sung, Jiyoon
    Ko, Kwang-Pil
    Kim, Dong Ki
    Jung, Ji Yong
    Lee, Hyun Hee
    Chung, Wookyung
    Kim, Sejoong
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2012, 27 (10) : 1177 - 1181